ArticleCancer medicine2025
Cancer Incidence in Kabul, Afghanistan: The First Report From the Population-Based Cancer Registry.
Article in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- The burden of childhood cancers in the South Asian Association for Regional Cooperation (SAARC) Region: a population-based, cross-sectional GLOBOCAN 2022 analysis.The Lancet regional health. Southeast Asia · 2026Article
- Observational
- The descriptive epidemiology of gastric cancer in Afghanistan: a population-based cancer registry, 2018-2020.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026Article
- The shifting balance: innate lymphoid cell plasticity in chronic gut diseases.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundEstablishing a population-based cancer registry is crucial for understanding cancer incidence, identifying risk factors, and developing effective cancer control programs. The Kabul Cancer Registry (KCR), Afghanistan's first population-based cancer registry, was established in 2018. The purpose of this study was to estimate the incidence of cancer in Kabul between 2018 and 2020.
methodsThe KCR, adhering to International Agency for Research on Cancer (IARC) standards, actively collected data on new cancer cases from health facilities in Kabul between 2018 and 2020. We used CanReg5 software to calculate age-standardized incidence rates (ASIRs) by cancer site in males and females, using the direct method with Segi's World Standard Population.
resultsThe KCR recorded 4498 new cancer cases among Kabul residents, with a male-to-female ratio of 0.82:1. The overall ASIR was 44.3 per 100,000 person-years in males and 60.9 in females. The top five cancer sites in males were stomach (ASIR = 9.1), esophagus (ASIR = 5.5), colorectum (ASIR = 3.7), lymphoma (ASIR = 2.4), and liver (ASIR = 2.1). In females, the top five cancer sites were breast (ASIR = 14.9), esophagus (ASIR = 6.7), stomach (ASIR = 4.2), colorectum (ASIR = 3.8), and gallbladder (ASIR = 1.8). Childhood cancers (aged 0-14 years) represented 6.8% of all cancers, with leukemia accounting for 43.5% of the new cancer cases.
conclusionsThe high incidence of breast, stomach, and esophagus cancers highlights the need for policymakers and healthcare providers to develop cancer control programs focused on primary prevention, early detection, and quality diagnosis and treatment. Additionally, this study underscores the importance of cancer registries and emphasizes the need to strengthen the KCR to improve data quality.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.